Could modifying gut microbes prevent or delay type 1 diabetes?

September 12, 2017 by Ziba Kashef
Credit: stock.adobe.com

Autoimmune diseases such as type 1 diabetes are controlled by our genes. While researchers are eager to find out what other factors could contribute to this disease, a new study published by Yale researchers provides direct evidence that environmental factors, such as microbes that inhabit our intestines, may influence the incidence of the disease.

To probe the microbes-diabetes connection, the Yale team modified the of mice by co-housing non-obese diabetic mice with animals that harbored altered microbes. They found co-housed non-obese diabetic mice were less susceptible to diabetes. This co-housing led to an increased number of known as regulatory T cells in the gut, which likely contribute to this beneficial outcome, according to the researchers. By giving mice antibodies that have been used to treat diabetes in human clinical trials, they also observed that same type of regulatory T cells were increased. These T cells were mobile, allowing them to migrate to inflamed organs and suppress the other pathogenic T cells that cause the development of type 1 diabetes.

"The findings could lead to more effective strategies to prevent or treat type 1 diabetes and other autoimmune conditions by boosting protective T cells in gut-associated tissues," said Hua Yu, a postdoctoral fellow at Yale School of Medicine and first author of the paper.

Senior author and Sterling Professor of Immunobiology Richard Flavell added: "These strategies might include dietary, probiotic, or pharmaceutical approaches. For example, manipulating a patient's diet to enrich good bacteria and increase intestinal regulatory T cells might be critically important in type 1 management." 

Explore further: 'Educating' patients' immune cells may help combat diabetes

More information: Hua Yu et al. Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1705599114

Related Stories

'Educating' patients' immune cells may help combat diabetes

July 7, 2017
New research reveals that a treatment called Stem Cell Educator therapy is safe and effective for treating type 1 and type 2 diabetes. The therapy cultures the patient's immune cells with cord blood stem cells and returns ...

Scientists study how some insulin-producing cells survive in type 1 diabetes

February 9, 2017
A Yale-led research team identified how insulin-producing cells that are typically destroyed in type 1 diabetes can change in order to survive immune attack. The finding may lead to strategies for recovering these cells in ...

How gut microbes may trigger type 1 diabetes

September 13, 2016
Research on the tiny microbes that live in our gut has yielded clues to understanding a growing number of medical conditions. A new Yale-led study explores the link between gut microbes and type 1 diabetes.

Bacteria that prevent type 1 diabetes

August 6, 2015
Our bodies have ten times more microbes than human cells. This set of bacteria is called microbiota. In some instances, bacteria known as pathogens can cause infectious diseases. However, these micro-organisms can also protect ...

New immune cell subset associated with progression to type 1 diabetes

October 11, 2016
A study conducted at the University of Eastern Finland revealed that a recently described T cell subset may have a central role in the development of type 1 diabetes. These so called follicular T helper cells were found to ...

Recommended for you

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Time to dial back on diabetes treatment in older patients? Study finds 11 percent are overtreated

September 14, 2017
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

gzurbay
not rated yet Sep 12, 2017
When diagnosed with type 2 diabetes ( fasting glucose ) - can it be theorized that microbes in the gut could be digesting food and creating sugars during sleep, - resulting in the elevated blood sugar, and would this suggest experimentation with mice? would a micro biome of diabetic humans ( type 2 ) induce type 2 in mice?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.